GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -66.7% | 108 | -58.6% | 0.00% | – |
| Q1 2022 | $9,000 | -71.9% | 261 | -76.4% | 0.00% | – |
| Q4 2021 | $32,000 | +28.0% | 1,106 | +15.0% | 0.00% | – |
| Q3 2021 | $25,000 | -16.7% | 962 | +11.1% | 0.00% | – |
| Q2 2021 | $30,000 | -16.7% | 866 | -2.0% | 0.00% | – |
| Q1 2021 | $36,000 | +227.3% | 884 | +233.6% | 0.00% | – |
| Q4 2020 | $11,000 | -21.4% | 265 | +6.0% | 0.00% | – |
| Q3 2020 | $14,000 | -22.2% | 250 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | -53.8% | 250 | -68.9% | 0.00% | -100.0% |
| Q3 2019 | $39,000 | -7.1% | 805 | +0.8% | 0.00% | -50.0% |
| Q2 2019 | $42,000 | – | 799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |